Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$903000.0.

  • PAVmed's Free Cash Flow changed N/A to -$903000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.7 million, marking a year-over-year change of. This contributed to the annual value of -$33.7 million for FY2024, which is 3562.3% up from last year.
  • As of Q3 2025, PAVmed's Free Cash Flow stood at -$903000.0.
  • PAVmed's Free Cash Flow's 5-year high stood at $44000.0 during Q4 2024, with a 5-year trough of -$22.9 million in Q2 2022.
  • Moreover, its 4-year median value for Free Cash Flow was -$12.4 million (2023), whereas its average is -$10.9 million.
  • In the last 5 years, PAVmed's Free Cash Flow crashed by 2766.22% in 2023 and then skyrocketed by 10036.49% in 2024.
  • PAVmed's Free Cash Flow (Quarter) stood at -$17.1 million in 2022, then increased by 29.58% to -$12.1 million in 2023, then surged by 100.36% to $44000.0 in 2024, then plummeted by 2152.27% to -$903000.0 in 2025.
  • Its Free Cash Flow stands at -$903000.0 for Q3 2025, versus -$1.2 million for Q2 2025 and -$1.6 million for Q1 2025.